Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. - Wikidata - wikimedia - TriplyDB

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

http://www.wikidata.org/entity/Q34147530

about

Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?BRCA1-mediated repression of select X chromosome genes Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related Hypoxia and Hypoxia-Inducible Factors in Leukemias HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics The impact of O2 availability on human cancer Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.Hypoxia as a biomarker for radioresistant cancer stem cells.Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.Clinicopathological Differences and Prognostic Value of Hypoxia-Inducible Factor-2α Expression for Gastric Cancer: Evidence From Meta-Analysis.Angiogenesis in upper tract urothelial carcinoma associated with Balkan endemic nephropathy.Cellular response to tissue hypoxia and its involvement in disease progression.Development of novel therapeutic strategies that target HIF-1.Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats.Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix HIF-1α and GLUT-1 Expression in Atypical Endometrial Hyperplasia, Type I and II Endometrial Carcinoma: A Potential Role in Pathogenesis.Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients.SIX1 is overexpressed in endometrial carcinoma and promotes the malignant behavior of cancer cells through ERK and AKT signaling.The investigation of tumoral angiogenesis with HIF-1 alpha and microvessel density in women with endometrium cancer.Hypoxia-mediated biological control.Progesterone: a pivotal hormone at menstruation.Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.Steroid regulation of menstrual bleeding and endometrial repair.Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.The potential role of HIF on tumour progression and dissemination.Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma.Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study.Stabilisation and knockdown of HIF--two distinct ways comparably important in radiotherapy.CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma.Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress.

P2860

Q24794814-194D1D7E-9015-4586-B669-4EA5BE030C44 Q24796376-791BA42E-5483-481A-8C0F-781EB4829CF8 Q24806403-435E8255-9B99-4DF1-A2D5-BE851616AD9F Q26767167-509D2BF6-3FFB-4319-8046-D637BBE50EFA Q27851557-B476DAA2-9FA9-42ED-A5E8-D3BD475C8E69 Q29615944-D0C67EBC-B18C-4A1A-8BBF-AD0A54B83950 Q29619884-922F277B-BD48-4A74-A8C8-B5FE251E8EDC Q33611310-A95CD642-7205-4220-A79F-9B309C3DE853 Q33652379-853727C1-B527-4DE6-B02A-5A27CB0811EE Q33739269-696D0778-596D-4F87-91EA-512268F7147B Q34420732-E76F3F48-4E9E-4835-9FFD-3B09FBFED081 Q35107985-73A16681-3963-4FBF-BB6F-75B18DF6315D Q35152277-4DBF8710-4A74-414E-B66E-419B63BFDC97 Q35586682-727A8C64-BF22-461E-AC93-FDB4AE93AE8F Q35625509-503DB250-8A14-40AF-8540-004F1D7FAC22 Q35926235-082AEAC8-CA58-414D-B4ED-A5291C8A56B4 Q36224953-09E6E6FF-FEB1-4C45-BDE3-6364705F29FA Q36268487-4639E4C5-F871-41AC-9BA4-33136B11E03C Q36425968-ACC86E2E-AF35-416F-B524-AC6382E08D51 Q36502592-2E8A1EDF-F026-46F2-8486-AE36434A4BCC Q36591911-D1E530DC-DC64-48D1-AF3F-E72FA04623ED Q36613493-02D824B7-98F8-4C41-B5D9-5EF7B38185DF Q37102611-4156B57B-ED16-451B-BB83-C35D3AD7884D Q37345218-CCDE79AF-49AF-42CA-8AD3-D69CFDB57549 Q37407005-75CD107F-A910-43F9-8A50-A2C6A4CCF806 Q37613335-58089201-38C7-4CB3-B83E-262E5AEFA05C Q37843943-A87FE24C-1492-4857-B791-412398C8A659 Q37852769-759B8CD9-3E53-4486-8B22-C317D75452BC Q37986039-3115336D-E30D-4E8B-862D-818C333E3519 Q38066022-D3B21D22-75A2-4BC8-BC71-61E6832C6055 Q38084610-F8B7B46C-B8F6-4DF8-AECF-C2E03993BA72 Q38204343-76C6531A-8E62-468D-AEAB-82FCD2A9C62F Q38303122-24F3D773-B002-45FB-9A5B-8DB4615B1840 Q38441223-492095B6-5746-4A8B-BCA7-A09FF611485C Q38788210-C27C15D0-4863-43EC-BF9C-E5FE2024F05A Q38803042-AE6682B1-21BD-485C-939C-0D8A9BA4B29F Q39396957-504674BC-9709-4501-9518-1D84944EA4A1 Q39426387-86E3AC6A-0E0E-493C-9F19-885D65723D9D Q40364138-86B9C8AE-4E36-48F7-B64F-240436576EC3 Q41781186-BD6A1F47-558D-4FBB-BC02-88331E3ED458

P2860

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

http://www.wikidata.org/entity/Q34147530

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@ast

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@en

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@nl

type

label

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@ast

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@en

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@nl

prefLabel

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@ast

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@en

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@nl

P1433

Q34147530-48AADD8D-EEE5-41A6-B97B-490AF4928288

P1476

Q34147530-0731681B-756B-4811-85B9-01E926029CD1

P2093

Q34147530-09393295-7C9A-4598-A517-A80F34DE0614

Q34147530-0C020526-8D70-4F07-A965-F9DCDC3890CA

Q34147530-2582691E-7D62-4D60-9DF8-D0F92D5CFF54

Q34147530-7AEF6809-12D2-4E91-896A-707BFA6EDB0C

Q34147530-F499B446-4664-4D33-A9E7-C25FA4CE9D99

P2860

Q34147530-2D9F18A7-61EA-4D5D-B017-C08216E0D1BB

Q34147530-3D0DB6B4-6B03-4063-8832-4F5B0EBA3AC7

Q34147530-4A4B9818-1F9D-42FC-9869-0898A49C0E4E

Q34147530-52C5C36C-E796-4F0D-BDEE-55C743DC2326

Q34147530-5D9274C7-6A0A-46D2-8FF2-D0DBF957F408

Q34147530-636F0645-DFAF-4C79-B557-67DCECFFDF4B

Q34147530-72E98742-E7FA-4DA2-8070-A4C2F8D73DC7

Q34147530-BA3EC85C-8BBB-4459-9257-6546C6DC236E

Q34147530-C39DE3CF-9FC2-4C4C-A2E8-F5FBEEF36704

Q34147530-D20B9FA4-EC13-4B7C-84AD-D2915A1F9984

P304

Q34147530-30185479-BE48-42EC-923F-51711CCDCCD4

P31

Q34147530-142F11DF-BEE0-44C9-B1DE-3603ADCEF3F1

P356

Q34147530-892F06D0-03C5-4F55-BF2A-B765A9D44B0C

P407

Q34147530-DC7562CC-8CCD-484B-9641-3E0F3C673E40

P433

Q34147530-65B80389-9E0B-463E-9FF6-4E2DED26CD1F

P478

Q34147530-F6BDA8B7-F1F3-4269-8175-A939446218CD

P50

Q34147530-EA429990-F5A2-43FC-9B0B-6DCD74FCA85E

P577

Q34147530-46A3AFB3-5B53-45D9-A6BA-75739FDDF62B

P5875

Q34147530-1F4AF019-9C90-485D-A2A8-B5B44C3F4094

P698

Q34147530-02CC8823-D331-4F50-A5CC-621A1A65E137

P921

Q34147530-42C78724-46E7-4B7E-9943-A5D6AE02CC02

Q34147530-F00DC50D-D202-49EF-92F1-7599145CB26B

P356

P1433

P1476

Association of hypoxia-inducib ...... ts with endometrial carcinoma.

@en

P2093

Alexandra Giatromanolaki

http://www.w3.org/2001/XMLSchema#string

Efthimios Sivridis

http://www.w3.org/2001/XMLSchema#string

Kevin C Gatter

http://www.w3.org/2001/XMLSchema#string

Michael I Koukourakis

http://www.w3.org/2001/XMLSchema#string

Tumor and Angiogenesis Research Group

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy.

Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.

Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT

Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.

Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.

Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.

P304

1055-1063

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.10774

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Adrian L Harris

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11178718

http://www.w3.org/2001/XMLSchema#string

P698

12209691

http://www.w3.org/2001/XMLSchema#string

P921